Global NCD Platform
Call for proposals: Implementation research on integrated care pathways to address NCDs and mental health conditions. Incentive Grants for Young Researchers from Low- and Middle-Income Countries
19 Nov 2024
World Health Organization | 24 May 2020
Fifty low- and middle-income countries are soon to receive insulin for people with diabetes, thanks to a donation by global health-care company, Novo Nordisk. The donation, of insulin and glucagon. to the value of US$ 1.3 million, comes at a time when many people with noncommunicable diseases such as diabetes are facing challenges with access to life-saving treatment as a result of the COVID-19 pandemic.
Read more here.